Annex 1 and Contamination Control Strategy

Piero Iamartino, pharmaceutical consultant and EIPG Technical and Professional Development Vice President, joined Making Connect for an interview focused on Annex 1 and CCS

19/09/2022

EIPG NEWS

In the current regulatory framework, manufacturers are required to develop a set of control strategies to confirm their process performance and product quality. 

In particular, the new EU GMP Annex 1 introduces a “Contamination Control Strategy” (CCS) approach to comply with these requirements by preventing microorganisms, pyrogens and particulates contamination in sterile medicinal products. Piero Iamartino, pharmaceutical consultant and EIPG Technical and Professional Development Vice President, joined Making Connect for an interview focused on Annex 1 and CCS. In this conversation, he also introduced the EIPG initiatives in support of its associates.

NEWS

Latest updates from the pharma world


Health&Biotech Accelerator | Deloitte Officine Innovazione

The ultimate goal of the Health&BioTech Accelerator is to identify the most innovative companies globally that meet the innovation goals that the life sciences field is heading for.


ISPE Summer Night 2023

The 2023 edition of the event, which took place on 28 June at the Mudec – Museum of Cultures of Milan, was dedicated to digitization and automation in the pharmaceutical sector


Trends for the future of the pharmaceutical manufacturing

It’s now mandatory the full implementation of the Industry 4.0 paradigm.